anti tra1 81 Search Results


94
Miltenyi Biotec 374460 rrid ab 10989468 facs tra
374460 Rrid Ab 10989468 Facs Tra, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/374460 rrid ab 10989468 facs tra/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
374460 rrid ab 10989468 facs tra - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

94
Bio-Techne corporation human/mouse ssea-1 pe-conjugated antibody
Human/Mouse Ssea 1 Pe Conjugated Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human/mouse ssea-1 pe-conjugated antibody/product/Bio-Techne corporation
Average 94 stars, based on 1 article reviews
human/mouse ssea-1 pe-conjugated antibody - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

90
Becton Dickinson pe mouse anti-human tra-1-81 antigen
( a ) Schematic summarizes the experimental strategy for determining 4F reprogramming efficiencies of FACS-purified hematopoietic progenitors of ( b ) BMSC-primed lineage-committed or ( c ) +/− BMSC-primed transgene-enriched myeloid populations. Experimental details are provided in . The %CD34 + gradient symbol above the schematic reflects the concept that multipotent primitive CD34+CD38lo stem-progenitors are enriched during Days -3 to -2, but differentiate rapidly in culture thereafter (see also Fig. 1c and Fig. S2a) . CD34 + CD38 lo stem-progenitors give rise to lineage-committed CD34 + CD38 + progenitors which subsequently differentiate further to CD34-negative CD33 + CD45 + myeloid cells ( e.g ., promyelocytes). Post-sort analysis of FACS-purified Day 0 CD34 + CD38 + CB fractions verified that >95% of this populations consisted of CD33 + CD13 + CD45 + myeloid cells (see also Fig. 1c ). Both reprogramming efficiency (AP and live <t>TRA-1-81</t> staining of hESC-like colonies) and reprogramming completion (bulk SSEA4 + TRA-1-81 + and NANOG + FACS staining) assays were conducted 4 weeks following 4F nucleofections on P 0 MEF cultures. ( b ) Shown is a representative AP staining (plates done in triplicate, with indicated average number of hESC-like colonies emerging per the number of single sorted day 3 BMSC-primed CB cells plated on MEF (i.e., unsorted CB vs. CD34 + CD38 lo vs. CD34 + CD38 + fractions. The averaged results of two independent experiments are indicated. In lower panels are shown representative FACS staining of surface TRA-1-81 and intracellular NANOG pluripotency markers of the same cultures demonstrating that 50–80% of AP + hESC-like colonies possessed a Type III TRA-1-81 + NANOG + phenotype . ( c ) To determine the more accurate reprogramming efficiency of purified +/− BMSC-primed episome-expressing myeloid populations, CB progenitors were co-nucleofected on day 0 with both the 4F pEP4 EO2S EM2K episome, as well as a pCEP4-GFP episomal GFP reporter construct. Episomal transgene expressing-only populations were subsequently FACS-purified by GFP expression prior to plating on day 3 MEF following with (+BMSC) or without (-BMSC) stromal co-culture. This was done by staining +/− BMSC-primed CB cells on day 3 with CD34-PE and FACS-purifying them into episome-expressing (GFP + CD34 + , GFP + CD34 − ), and non episome-expressing (GFP − ) populations prior to MEF plating. The results of AP stained plates shown are representative of independent sorting experiments using pooled donor CB samples for each 4F nucleofection, with the averaged results of two independent experiments indicated below. FACS analysis of these same experiments (data not shown) revealed 60% TRA-1-81 and NANOG expression for +BMSC AP + colonies (GFP + CD34 − ), and 55% TRA-1-81 expression for –BMSC AP + colonies (GFP + CD34 − ).
Pe Mouse Anti Human Tra 1 81 Antigen, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pe mouse anti-human tra-1-81 antigen/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
pe mouse anti-human tra-1-81 antigen - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
GeneTex antibodies anti-tra-1-81 gtx48034
( a ) Schematic summarizes the experimental strategy for determining 4F reprogramming efficiencies of FACS-purified hematopoietic progenitors of ( b ) BMSC-primed lineage-committed or ( c ) +/− BMSC-primed transgene-enriched myeloid populations. Experimental details are provided in . The %CD34 + gradient symbol above the schematic reflects the concept that multipotent primitive CD34+CD38lo stem-progenitors are enriched during Days -3 to -2, but differentiate rapidly in culture thereafter (see also Fig. 1c and Fig. S2a) . CD34 + CD38 lo stem-progenitors give rise to lineage-committed CD34 + CD38 + progenitors which subsequently differentiate further to CD34-negative CD33 + CD45 + myeloid cells ( e.g ., promyelocytes). Post-sort analysis of FACS-purified Day 0 CD34 + CD38 + CB fractions verified that >95% of this populations consisted of CD33 + CD13 + CD45 + myeloid cells (see also Fig. 1c ). Both reprogramming efficiency (AP and live <t>TRA-1-81</t> staining of hESC-like colonies) and reprogramming completion (bulk SSEA4 + TRA-1-81 + and NANOG + FACS staining) assays were conducted 4 weeks following 4F nucleofections on P 0 MEF cultures. ( b ) Shown is a representative AP staining (plates done in triplicate, with indicated average number of hESC-like colonies emerging per the number of single sorted day 3 BMSC-primed CB cells plated on MEF (i.e., unsorted CB vs. CD34 + CD38 lo vs. CD34 + CD38 + fractions. The averaged results of two independent experiments are indicated. In lower panels are shown representative FACS staining of surface TRA-1-81 and intracellular NANOG pluripotency markers of the same cultures demonstrating that 50–80% of AP + hESC-like colonies possessed a Type III TRA-1-81 + NANOG + phenotype . ( c ) To determine the more accurate reprogramming efficiency of purified +/− BMSC-primed episome-expressing myeloid populations, CB progenitors were co-nucleofected on day 0 with both the 4F pEP4 EO2S EM2K episome, as well as a pCEP4-GFP episomal GFP reporter construct. Episomal transgene expressing-only populations were subsequently FACS-purified by GFP expression prior to plating on day 3 MEF following with (+BMSC) or without (-BMSC) stromal co-culture. This was done by staining +/− BMSC-primed CB cells on day 3 with CD34-PE and FACS-purifying them into episome-expressing (GFP + CD34 + , GFP + CD34 − ), and non episome-expressing (GFP − ) populations prior to MEF plating. The results of AP stained plates shown are representative of independent sorting experiments using pooled donor CB samples for each 4F nucleofection, with the averaged results of two independent experiments indicated below. FACS analysis of these same experiments (data not shown) revealed 60% TRA-1-81 and NANOG expression for +BMSC AP + colonies (GFP + CD34 − ), and 55% TRA-1-81 expression for –BMSC AP + colonies (GFP + CD34 − ).
Antibodies Anti Tra 1 81 Gtx48034, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies anti-tra-1-81 gtx48034/product/GeneTex
Average 90 stars, based on 1 article reviews
antibodies anti-tra-1-81 gtx48034 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Applied StemCell Inc anti-tra-1-81
( a ) Schematic summarizes the experimental strategy for determining 4F reprogramming efficiencies of FACS-purified hematopoietic progenitors of ( b ) BMSC-primed lineage-committed or ( c ) +/− BMSC-primed transgene-enriched myeloid populations. Experimental details are provided in . The %CD34 + gradient symbol above the schematic reflects the concept that multipotent primitive CD34+CD38lo stem-progenitors are enriched during Days -3 to -2, but differentiate rapidly in culture thereafter (see also Fig. 1c and Fig. S2a) . CD34 + CD38 lo stem-progenitors give rise to lineage-committed CD34 + CD38 + progenitors which subsequently differentiate further to CD34-negative CD33 + CD45 + myeloid cells ( e.g ., promyelocytes). Post-sort analysis of FACS-purified Day 0 CD34 + CD38 + CB fractions verified that >95% of this populations consisted of CD33 + CD13 + CD45 + myeloid cells (see also Fig. 1c ). Both reprogramming efficiency (AP and live <t>TRA-1-81</t> staining of hESC-like colonies) and reprogramming completion (bulk SSEA4 + TRA-1-81 + and NANOG + FACS staining) assays were conducted 4 weeks following 4F nucleofections on P 0 MEF cultures. ( b ) Shown is a representative AP staining (plates done in triplicate, with indicated average number of hESC-like colonies emerging per the number of single sorted day 3 BMSC-primed CB cells plated on MEF (i.e., unsorted CB vs. CD34 + CD38 lo vs. CD34 + CD38 + fractions. The averaged results of two independent experiments are indicated. In lower panels are shown representative FACS staining of surface TRA-1-81 and intracellular NANOG pluripotency markers of the same cultures demonstrating that 50–80% of AP + hESC-like colonies possessed a Type III TRA-1-81 + NANOG + phenotype . ( c ) To determine the more accurate reprogramming efficiency of purified +/− BMSC-primed episome-expressing myeloid populations, CB progenitors were co-nucleofected on day 0 with both the 4F pEP4 EO2S EM2K episome, as well as a pCEP4-GFP episomal GFP reporter construct. Episomal transgene expressing-only populations were subsequently FACS-purified by GFP expression prior to plating on day 3 MEF following with (+BMSC) or without (-BMSC) stromal co-culture. This was done by staining +/− BMSC-primed CB cells on day 3 with CD34-PE and FACS-purifying them into episome-expressing (GFP + CD34 + , GFP + CD34 − ), and non episome-expressing (GFP − ) populations prior to MEF plating. The results of AP stained plates shown are representative of independent sorting experiments using pooled donor CB samples for each 4F nucleofection, with the averaged results of two independent experiments indicated below. FACS analysis of these same experiments (data not shown) revealed 60% TRA-1-81 and NANOG expression for +BMSC AP + colonies (GFP + CD34 − ), and 55% TRA-1-81 expression for –BMSC AP + colonies (GFP + CD34 − ).
Anti Tra 1 81, supplied by Applied StemCell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-tra-1-81/product/Applied StemCell Inc
Average 90 stars, based on 1 article reviews
anti-tra-1-81 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

91
Bio-Techne corporation human tra-1-81 antibody
( a ) Schematic summarizes the experimental strategy for determining 4F reprogramming efficiencies of FACS-purified hematopoietic progenitors of ( b ) BMSC-primed lineage-committed or ( c ) +/− BMSC-primed transgene-enriched myeloid populations. Experimental details are provided in . The %CD34 + gradient symbol above the schematic reflects the concept that multipotent primitive CD34+CD38lo stem-progenitors are enriched during Days -3 to -2, but differentiate rapidly in culture thereafter (see also Fig. 1c and Fig. S2a) . CD34 + CD38 lo stem-progenitors give rise to lineage-committed CD34 + CD38 + progenitors which subsequently differentiate further to CD34-negative CD33 + CD45 + myeloid cells ( e.g ., promyelocytes). Post-sort analysis of FACS-purified Day 0 CD34 + CD38 + CB fractions verified that >95% of this populations consisted of CD33 + CD13 + CD45 + myeloid cells (see also Fig. 1c ). Both reprogramming efficiency (AP and live <t>TRA-1-81</t> staining of hESC-like colonies) and reprogramming completion (bulk SSEA4 + TRA-1-81 + and NANOG + FACS staining) assays were conducted 4 weeks following 4F nucleofections on P 0 MEF cultures. ( b ) Shown is a representative AP staining (plates done in triplicate, with indicated average number of hESC-like colonies emerging per the number of single sorted day 3 BMSC-primed CB cells plated on MEF (i.e., unsorted CB vs. CD34 + CD38 lo vs. CD34 + CD38 + fractions. The averaged results of two independent experiments are indicated. In lower panels are shown representative FACS staining of surface TRA-1-81 and intracellular NANOG pluripotency markers of the same cultures demonstrating that 50–80% of AP + hESC-like colonies possessed a Type III TRA-1-81 + NANOG + phenotype . ( c ) To determine the more accurate reprogramming efficiency of purified +/− BMSC-primed episome-expressing myeloid populations, CB progenitors were co-nucleofected on day 0 with both the 4F pEP4 EO2S EM2K episome, as well as a pCEP4-GFP episomal GFP reporter construct. Episomal transgene expressing-only populations were subsequently FACS-purified by GFP expression prior to plating on day 3 MEF following with (+BMSC) or without (-BMSC) stromal co-culture. This was done by staining +/− BMSC-primed CB cells on day 3 with CD34-PE and FACS-purifying them into episome-expressing (GFP + CD34 + , GFP + CD34 − ), and non episome-expressing (GFP − ) populations prior to MEF plating. The results of AP stained plates shown are representative of independent sorting experiments using pooled donor CB samples for each 4F nucleofection, with the averaged results of two independent experiments indicated below. FACS analysis of these same experiments (data not shown) revealed 60% TRA-1-81 and NANOG expression for +BMSC AP + colonies (GFP + CD34 − ), and 55% TRA-1-81 expression for –BMSC AP + colonies (GFP + CD34 − ).
Human Tra 1 81 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human tra-1-81 antibody/product/Bio-Techne corporation
Average 91 stars, based on 1 article reviews
human tra-1-81 antibody - by Bioz Stars, 2026-05
91/100 stars
  Buy from Supplier

N/A
Isotype Note IgM kappa Host Species Note Mouse Reactivity Note Human Rat Rhesus
  Buy from Supplier

N/A
Alexa Fluor 594 anti-human TRA-1-81 [TRA-1-81]; Isotype: Mouse IgM, κ; Reactivity: Human; Apps: IF; Size: 100 μg
  Buy from Supplier


N/A
Isotype Note IgM kappa Host Species Note Mouse Reactivity Note Human Rat Rhesus
  Buy from Supplier

N/A
Isotype Note IgM kappa Host Species Note Mouse Reactivity Note Human Rat Rhesus
  Buy from Supplier

N/A
Alexa Fluor 488 anti-human TRA-1-81 [TRA-1-81]; Isotype: Mouse IgM, κ; Reactivity: Human; Apps: FC, IF; Size: 25 tests
  Buy from Supplier

Image Search Results


( a ) Schematic summarizes the experimental strategy for determining 4F reprogramming efficiencies of FACS-purified hematopoietic progenitors of ( b ) BMSC-primed lineage-committed or ( c ) +/− BMSC-primed transgene-enriched myeloid populations. Experimental details are provided in . The %CD34 + gradient symbol above the schematic reflects the concept that multipotent primitive CD34+CD38lo stem-progenitors are enriched during Days -3 to -2, but differentiate rapidly in culture thereafter (see also Fig. 1c and Fig. S2a) . CD34 + CD38 lo stem-progenitors give rise to lineage-committed CD34 + CD38 + progenitors which subsequently differentiate further to CD34-negative CD33 + CD45 + myeloid cells ( e.g ., promyelocytes). Post-sort analysis of FACS-purified Day 0 CD34 + CD38 + CB fractions verified that >95% of this populations consisted of CD33 + CD13 + CD45 + myeloid cells (see also Fig. 1c ). Both reprogramming efficiency (AP and live TRA-1-81 staining of hESC-like colonies) and reprogramming completion (bulk SSEA4 + TRA-1-81 + and NANOG + FACS staining) assays were conducted 4 weeks following 4F nucleofections on P 0 MEF cultures. ( b ) Shown is a representative AP staining (plates done in triplicate, with indicated average number of hESC-like colonies emerging per the number of single sorted day 3 BMSC-primed CB cells plated on MEF (i.e., unsorted CB vs. CD34 + CD38 lo vs. CD34 + CD38 + fractions. The averaged results of two independent experiments are indicated. In lower panels are shown representative FACS staining of surface TRA-1-81 and intracellular NANOG pluripotency markers of the same cultures demonstrating that 50–80% of AP + hESC-like colonies possessed a Type III TRA-1-81 + NANOG + phenotype . ( c ) To determine the more accurate reprogramming efficiency of purified +/− BMSC-primed episome-expressing myeloid populations, CB progenitors were co-nucleofected on day 0 with both the 4F pEP4 EO2S EM2K episome, as well as a pCEP4-GFP episomal GFP reporter construct. Episomal transgene expressing-only populations were subsequently FACS-purified by GFP expression prior to plating on day 3 MEF following with (+BMSC) or without (-BMSC) stromal co-culture. This was done by staining +/− BMSC-primed CB cells on day 3 with CD34-PE and FACS-purifying them into episome-expressing (GFP + CD34 + , GFP + CD34 − ), and non episome-expressing (GFP − ) populations prior to MEF plating. The results of AP stained plates shown are representative of independent sorting experiments using pooled donor CB samples for each 4F nucleofection, with the averaged results of two independent experiments indicated below. FACS analysis of these same experiments (data not shown) revealed 60% TRA-1-81 and NANOG expression for +BMSC AP + colonies (GFP + CD34 − ), and 55% TRA-1-81 expression for –BMSC AP + colonies (GFP + CD34 − ).

Journal: PLoS ONE

Article Title: Growth Factor-Activated Stem Cell Circuits and Stromal Signals Cooperatively Accelerate Non-Integrated iPSC Reprogramming of Human Myeloid Progenitors

doi: 10.1371/journal.pone.0042838

Figure Lengend Snippet: ( a ) Schematic summarizes the experimental strategy for determining 4F reprogramming efficiencies of FACS-purified hematopoietic progenitors of ( b ) BMSC-primed lineage-committed or ( c ) +/− BMSC-primed transgene-enriched myeloid populations. Experimental details are provided in . The %CD34 + gradient symbol above the schematic reflects the concept that multipotent primitive CD34+CD38lo stem-progenitors are enriched during Days -3 to -2, but differentiate rapidly in culture thereafter (see also Fig. 1c and Fig. S2a) . CD34 + CD38 lo stem-progenitors give rise to lineage-committed CD34 + CD38 + progenitors which subsequently differentiate further to CD34-negative CD33 + CD45 + myeloid cells ( e.g ., promyelocytes). Post-sort analysis of FACS-purified Day 0 CD34 + CD38 + CB fractions verified that >95% of this populations consisted of CD33 + CD13 + CD45 + myeloid cells (see also Fig. 1c ). Both reprogramming efficiency (AP and live TRA-1-81 staining of hESC-like colonies) and reprogramming completion (bulk SSEA4 + TRA-1-81 + and NANOG + FACS staining) assays were conducted 4 weeks following 4F nucleofections on P 0 MEF cultures. ( b ) Shown is a representative AP staining (plates done in triplicate, with indicated average number of hESC-like colonies emerging per the number of single sorted day 3 BMSC-primed CB cells plated on MEF (i.e., unsorted CB vs. CD34 + CD38 lo vs. CD34 + CD38 + fractions. The averaged results of two independent experiments are indicated. In lower panels are shown representative FACS staining of surface TRA-1-81 and intracellular NANOG pluripotency markers of the same cultures demonstrating that 50–80% of AP + hESC-like colonies possessed a Type III TRA-1-81 + NANOG + phenotype . ( c ) To determine the more accurate reprogramming efficiency of purified +/− BMSC-primed episome-expressing myeloid populations, CB progenitors were co-nucleofected on day 0 with both the 4F pEP4 EO2S EM2K episome, as well as a pCEP4-GFP episomal GFP reporter construct. Episomal transgene expressing-only populations were subsequently FACS-purified by GFP expression prior to plating on day 3 MEF following with (+BMSC) or without (-BMSC) stromal co-culture. This was done by staining +/− BMSC-primed CB cells on day 3 with CD34-PE and FACS-purifying them into episome-expressing (GFP + CD34 + , GFP + CD34 − ), and non episome-expressing (GFP − ) populations prior to MEF plating. The results of AP stained plates shown are representative of independent sorting experiments using pooled donor CB samples for each 4F nucleofection, with the averaged results of two independent experiments indicated below. FACS analysis of these same experiments (data not shown) revealed 60% TRA-1-81 and NANOG expression for +BMSC AP + colonies (GFP + CD34 − ), and 55% TRA-1-81 expression for –BMSC AP + colonies (GFP + CD34 − ).

Article Snippet: Antibodies included APC conjugated SSEA4 (R&D Systems), PE Mouse anti-Human TRA-1-60 antigen (BD Biosciences) and PE Mouse anti-Human TRA-1-81 antigen (BD Biosciences).

Techniques: Purification, Staining, Expressing, Construct, Co-Culture Assay

( a ) Illumina microarray expressions of ESC-like gene modules (MYC, PRC1, PRC2, and Core; see for gene lists). Shown are donor cell populations with (+) and without (−) 4F episomal nucleofections, and with (+) and without (−) BMSC-priming: adult fibroblasts (F), Day -3 unstimulated CB cells (D-3 CB), Day 0 FTK GF-stimulated CB cells (D0), Day 3+/− BMSC-primed (D3), and bulk Day 23 early CB-iPSC culture (D23 iPSC). These early D23 iPSC populations were already composed of >50–60% populations with fully-reprogrammed TRA-1-81 + NANOG + phenotypes. Undifferentiated H9 hESC samples served as control (hESC). Module expressions represent log2 mean-subtracted normalized values of signal intensities from averaged, independent biological replicate microarray samples (n = 3 per condition). Although they possessed a transcriptionally inactive Core module, day 0 GF-activated CB progenitors expressed active ESC and MYC modules, and inactive PRC1, and PRC2 modules at mean expression levels that were already comparable to levels in hESC. The annotation and references of all genes in each module is provided in . ( b ) Partially reprogrammed ESC module expression in CB progenitors. Legend for each sample is the same as above. Unsupervised hierarchical clustering heatmaps of ( b ) expression and ( c ) Box plots of log2 mean-normalized values of the ESC module gene signal intensities in somatic target populations, hESC, and reprogrammed cell lines. The heatmap’s color scale was chosen to emphasize subtle mid-range change. The resulting values emphasize relative expression across cell types rather than relative absolute expression across genes. This box and whisker plots (right panels) depict the log2 mean-subtracted normalized values of signal intensities of genes comprising the module set for each cell type indicated from Illumina array data. The top and bottom of a box mark the 75 th and 25 th percentile log2 signal values, respectively, while the bar at the middle denotes the median. The whiskers above and below each box mark the upper 90 th and lower 10 th percentiles. Paired tests with significance p <0.05 (*) or without significance ( NS ; p>0.05) with values of control hESC are indicated.

Journal: PLoS ONE

Article Title: Growth Factor-Activated Stem Cell Circuits and Stromal Signals Cooperatively Accelerate Non-Integrated iPSC Reprogramming of Human Myeloid Progenitors

doi: 10.1371/journal.pone.0042838

Figure Lengend Snippet: ( a ) Illumina microarray expressions of ESC-like gene modules (MYC, PRC1, PRC2, and Core; see for gene lists). Shown are donor cell populations with (+) and without (−) 4F episomal nucleofections, and with (+) and without (−) BMSC-priming: adult fibroblasts (F), Day -3 unstimulated CB cells (D-3 CB), Day 0 FTK GF-stimulated CB cells (D0), Day 3+/− BMSC-primed (D3), and bulk Day 23 early CB-iPSC culture (D23 iPSC). These early D23 iPSC populations were already composed of >50–60% populations with fully-reprogrammed TRA-1-81 + NANOG + phenotypes. Undifferentiated H9 hESC samples served as control (hESC). Module expressions represent log2 mean-subtracted normalized values of signal intensities from averaged, independent biological replicate microarray samples (n = 3 per condition). Although they possessed a transcriptionally inactive Core module, day 0 GF-activated CB progenitors expressed active ESC and MYC modules, and inactive PRC1, and PRC2 modules at mean expression levels that were already comparable to levels in hESC. The annotation and references of all genes in each module is provided in . ( b ) Partially reprogrammed ESC module expression in CB progenitors. Legend for each sample is the same as above. Unsupervised hierarchical clustering heatmaps of ( b ) expression and ( c ) Box plots of log2 mean-normalized values of the ESC module gene signal intensities in somatic target populations, hESC, and reprogrammed cell lines. The heatmap’s color scale was chosen to emphasize subtle mid-range change. The resulting values emphasize relative expression across cell types rather than relative absolute expression across genes. This box and whisker plots (right panels) depict the log2 mean-subtracted normalized values of signal intensities of genes comprising the module set for each cell type indicated from Illumina array data. The top and bottom of a box mark the 75 th and 25 th percentile log2 signal values, respectively, while the bar at the middle denotes the median. The whiskers above and below each box mark the upper 90 th and lower 10 th percentiles. Paired tests with significance p <0.05 (*) or without significance ( NS ; p>0.05) with values of control hESC are indicated.

Article Snippet: Antibodies included APC conjugated SSEA4 (R&D Systems), PE Mouse anti-Human TRA-1-60 antigen (BD Biosciences) and PE Mouse anti-Human TRA-1-81 antigen (BD Biosciences).

Techniques: Microarray, Expressing, Whisker Assay

( a ) Emergence of surface pluripotency markers (SSEA4, TRA-1-81) were assayed by FACS at 3 weeks in bulk cultures of 4F episomally-reprogrammed somatic cells briefly co-cultured with (+) or without ( − ) irradiated BMSC ( Fig. S1 ). Fetal fibroblasts (FFB), adult fibroblasts (AdFib), adult keratinocytes (Ker), and GF-activated Day 0 CB (CB) were nucleofected with 4F or 7F on Day 0 ( Fig. S1 ), and reprogrammed bulk cultures were analyzed by FACS 3 weeks later. AP stains of hESC-like colonies were done in parallel of these same experiments, and are presented in Fig. 1d . Shown are the averaged results of 2–5 experiments with averages, and significances ( * ) designated at peak of bar graphs. ( b,c ) The kinetics of pluripotency marker emergence of 4F reprogrammed CB progenitors with (+) and without (−) BMSC priming. ( b ) SSEA4 + , and ( c ) SSEA4 + TRA-1-60 + expressions. ( d ) Enhancement of 4F CB reprogramming with (+BMSC) and without (- BMSC) stromal priming was due to signals that were partially cell contact-dependent, and partially soluble factor-mediated. GF-activated CB cells were cultured as described in Fig. S1 from Day 0 until Day 3 without BMSC co-culture (-BMSC), with BMSC co-culture (+BMSC), or with BMSC co-culture but physically separated from CB cells with a Transwell insert that prevented cell-cell contact between BMSC and CB cells, but allowed diffusion of soluble stromal factors (+BMSC (T)). Shown is the relative fold-increase of reprogramming efficiency (enumerated AP+ hESC-like colonies) from two averaged 4F-reprogramming experiments from baseline efficiencies (-BMSC conditions). Reprogramming efficiency was determined at 3 weeks post-nucleofection with 4F, determined by AP staining of hESC-like colonies (as described in ). ( e ) Gene specific enrichment analysis (GSEA) computation of pathways activated in 4F-nucleofected CB cells by stromal signals. The GSEA algorithm was used to identify curated pathways over-represented among genes with significant (p<0.05, FDR<0.05) differential expression between Day 3 (D3) +BMSC-primed CB samples, vs . D3 unprimed (-BMSC) CB samples that were nucleofected at Day 0 with 4F episome. summarizes the MSigDB v. 3.0 gene set categories that were enriched with FDR <0.05 and nom p <0.05 for these two paired gene set computations. Shown in ( e ) are the major categories of enriched pathways that were significantly and differentially activated in Day 3 BMSC-primed and 4F-nucleofected CB samples.

Journal: PLoS ONE

Article Title: Growth Factor-Activated Stem Cell Circuits and Stromal Signals Cooperatively Accelerate Non-Integrated iPSC Reprogramming of Human Myeloid Progenitors

doi: 10.1371/journal.pone.0042838

Figure Lengend Snippet: ( a ) Emergence of surface pluripotency markers (SSEA4, TRA-1-81) were assayed by FACS at 3 weeks in bulk cultures of 4F episomally-reprogrammed somatic cells briefly co-cultured with (+) or without ( − ) irradiated BMSC ( Fig. S1 ). Fetal fibroblasts (FFB), adult fibroblasts (AdFib), adult keratinocytes (Ker), and GF-activated Day 0 CB (CB) were nucleofected with 4F or 7F on Day 0 ( Fig. S1 ), and reprogrammed bulk cultures were analyzed by FACS 3 weeks later. AP stains of hESC-like colonies were done in parallel of these same experiments, and are presented in Fig. 1d . Shown are the averaged results of 2–5 experiments with averages, and significances ( * ) designated at peak of bar graphs. ( b,c ) The kinetics of pluripotency marker emergence of 4F reprogrammed CB progenitors with (+) and without (−) BMSC priming. ( b ) SSEA4 + , and ( c ) SSEA4 + TRA-1-60 + expressions. ( d ) Enhancement of 4F CB reprogramming with (+BMSC) and without (- BMSC) stromal priming was due to signals that were partially cell contact-dependent, and partially soluble factor-mediated. GF-activated CB cells were cultured as described in Fig. S1 from Day 0 until Day 3 without BMSC co-culture (-BMSC), with BMSC co-culture (+BMSC), or with BMSC co-culture but physically separated from CB cells with a Transwell insert that prevented cell-cell contact between BMSC and CB cells, but allowed diffusion of soluble stromal factors (+BMSC (T)). Shown is the relative fold-increase of reprogramming efficiency (enumerated AP+ hESC-like colonies) from two averaged 4F-reprogramming experiments from baseline efficiencies (-BMSC conditions). Reprogramming efficiency was determined at 3 weeks post-nucleofection with 4F, determined by AP staining of hESC-like colonies (as described in ). ( e ) Gene specific enrichment analysis (GSEA) computation of pathways activated in 4F-nucleofected CB cells by stromal signals. The GSEA algorithm was used to identify curated pathways over-represented among genes with significant (p<0.05, FDR<0.05) differential expression between Day 3 (D3) +BMSC-primed CB samples, vs . D3 unprimed (-BMSC) CB samples that were nucleofected at Day 0 with 4F episome. summarizes the MSigDB v. 3.0 gene set categories that were enriched with FDR <0.05 and nom p <0.05 for these two paired gene set computations. Shown in ( e ) are the major categories of enriched pathways that were significantly and differentially activated in Day 3 BMSC-primed and 4F-nucleofected CB samples.

Article Snippet: Antibodies included APC conjugated SSEA4 (R&D Systems), PE Mouse anti-Human TRA-1-60 antigen (BD Biosciences) and PE Mouse anti-Human TRA-1-81 antigen (BD Biosciences).

Techniques: Cell Culture, Irradiation, Marker, Co-Culture Assay, Diffusion-based Assay, Staining, Expressing